Delivery Order SPE2DB24D2205-SPE2DB25FEGVA
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,633.36 for Xulane 150-35 mcg/day transdermal patches (3-count) on June 24, 2025, with an ultimate completion date of June 25, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award conditions. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $3,040.92 to AmerisourceBergen Drug Corp for Xulane 150-35 microgram/day transdermal patches (three-count packaging). This firm fixed-price, non-set-aside contract was executed on August 7, 2025, with an ultimate completion date of August 8, 2025, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,179.78 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day transdermal patches (3-count) on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. As a child contract, this delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,015.60 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day transdermal patches (3-count package). The contract, issued on April 21, 2025, with an ultimate completion date of April 22, 2025, represents a firm fixed-price delivery order with no set-aside designation. The place of performance is located at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract executed...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,610.48 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day transdermal patches (3-unit supply) on June 20, 2025, with an ultimate completion date of June 23, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a delivery order valued at $5,477.59 to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Xulane 150-35 mcg/day transdermal patches (3-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of June 3, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this delivery order is executed...
- The Defense Logistics Agency awarded a $1,299.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for XULANE 150-35 mcg/day patches (3-unit supply) on September 16, 2025, with completion scheduled for September 17, 2025. This non-set-aside contract is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for $4,418.88 to supply Xulane 150-35 mcg/day transdermal patches (quantity: 3 units). This is a firm fixed price delivery order with no set-aside designation, completed competitively under the company's larger indefinite delivery contract with DLA Troop Support Medical. The order is set to be fulfilled by the ultimate completion date of August 13, 2025, with the place of performance in...
- The Defense Logistics Agency awarded a delivery order valued at $10,623.13 to AmerisourceBergen Drug Corp for XULANE 150-35 MCG/DAY patches (a three-pack contraceptive transdermal patch). This firm fixed price, competitively awarded delivery order is scheduled for completion by September 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a non-set-aside procurement executed through the agency's established...
- The Defense Logistics Agency awarded a delivery order valued at $1,642.20 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day patches (quantity: 3) with a firm fixed price structure. The contract, issued on July 22, 2025, with an ultimate completion date of July 23, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location in...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEGVADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,948.40 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day transdermal patches (3-count package), effective August 26, 2025, with completion targeted for August 27, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performs under this delivery order at its corporate office location. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as the company's primary vehicle for supplying pharmaceutical products and medical supplies to military healthcare systems globally. The pharmaceutical prime vendor contract enables AmerisourceBergen to deliver a comprehensive range of medications, vaccines, and medical commodities to support Defense Health Agency operations and other federal healthcare customers. The Xulane patch, a hormonal contraceptive, represents one of many therapeutic medications the contractor supplies under this expansive federal medical procurement framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 8/26/25 |